Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Activation and Modulation”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableUnknownNCT04436263
What this trial is testing

Cardioprotective Properties of Natural Anti-Platelet Activating Factor Extract From Winery By-products in Healthy Women

Who this might be right for
Platelet Aggregation and Inflammation
Harokopio University 15
Not applicableStudy completedNCT01643369
What this trial is testing

The Sounds of Compassion: Testing How Specific Elements of Meditation Change Daily Life

Who this might be right for
Immune System ProcessesInflammatory Activation and ModulationANS Function
University of Arizona 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT05611710
What this trial is testing

Anakinra in Dengue With Hyperinflammation ( AnaDen )

Who this might be right for
DengueDengue With Warning SignsSevere Dengue+6 more
Oxford University Clinical Research Unit, Vietnam 160
Not applicableStudy completedNCT01251341
What this trial is testing

The Compassion and Attention Longitudinal Meditation Study

Who this might be right for
Immune System ProcessesInflammatory Activation and ModulationANS Function
University of Arizona 226
Not applicableStudy completedNCT05542147
What this trial is testing

Genetic-Dependent Cardiovascular Response to PPAR-Alpha Agonist Fenofibrate

Who this might be right for
Type 2 DiabetesCardiovascular DiseasesPharmacogenomic Drug Interaction
Mario Luca Morieri 200
Post-approval studies (Phase 4)Study completedNCT02885168
What this trial is testing

Modulation of Vasoreactivity in Septic Shock: Impact of Recombinant Protein C

Who this might be right for
Septic Shock
Central Hospital, Nancy, France 30